¥2,397.00
0.74% today
Tokyo, Nov 06, 07:15 am CET
ISIN
JP3256000005
Symbol
4151
Index

Kyowa Kirin Stock price

¥2,399.00
-4.00 0.17% 1M
+208.00 9.49% 6M
+23.50 0.99% YTD
-173.00 6.73% 1Y
-821.00 25.50% 3Y
-426.00 15.08% 5Y
+334.00 16.17% 10Y
+1,550.00 182.57% 20Y
Tokyo, Closing price Thu, Nov 06 2025
+19.50 0.82%
ISIN
JP3256000005
Symbol
4151
Index
Industry

Key metrics

Basic
Market capitalization
¥1.2t
Enterprise Value
¥1.0t
Net debt
positive
Cash
¥242.2b
Shares outstanding
523.5m
Valuation (TTM | estimate)
P/E
34.1 | 22.6
P/S
2.6 | 2.6
EV/Sales
2.1 | 2.1
EV/FCF
negative
P/B
1.5
Dividends
DPS
¥60.00
Yield 1Y | 5Y
2.5% | 1.9%
Growth 1Y | 5Y
3.4% | 6.4%
Payout 1Y | 3Y
51.3% | 45.4%
Increased
9 Years
Financials (TTM | estimate)
Revenue
¥482.2b | ¥482.9b
EBITDA
¥90.2b | ¥107.6b
EBIT
¥65.4b | ¥99.0b
Net Income
¥36.6b | ¥55.1b
Free Cash Flow
¥-30.4b
Growth (TTM | estimate)
Revenue
-3.4% | -2.6%
EBITDA
-27.7% | 4.9%
EBIT
-34.8% | 9.1%
Net Income
-56.2% | -7.9%
Free Cash Flow
-166.0%
Margin (TTM | estimate)
Gross
73.3%
EBITDA
18.7% | 22.3%
EBIT
13.6%
Net
7.6% | 11.4%
Free Cash Flow
-6.3%
Financial Health
Equity Ratio
79.7%
Return on Equity
7.0%
ROCE
7.3%
ROIC
6.2%
Debt/Equity
0.0
More
EPS
¥69.9
FCF per Share
¥-58.1
Short interest
-
Employees
6k
Rev per Employee
¥87.4m
Show more

Is Kyowa Kirin a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,024 stocks worldwide.

Kyowa Kirin Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a Kyowa Kirin forecast:

7x Buy
47%
7x Hold
47%
1x Sell
7%

Analyst Opinions

15 Analysts have issued a Kyowa Kirin forecast:

Buy
47%
Hold
47%
Sell
7%

Financial data from Kyowa Kirin

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
482,211 482,211
3% 3%
100%
- Direct Costs 128,666 128,666
0% 0%
27%
353,545 353,545
5% 5%
73%
- Selling and Administrative Expenses 165,468 165,468
4% 4%
34%
- Research and Development Expense 106,086 106,086
11% 11%
22%
90,166 90,166
28% 28%
19%
- Depreciation and Amortization 24,734 24,734
1% 1%
5%
EBIT (Operating Income) EBIT 65,432 65,432
35% 35%
14%
Net Profit 36,568 36,568
56% 56%
8%

In millions JPY.

Don't miss a Thing! We will send you all news about Kyowa Kirin directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Kyowa Kirin Co., Ltd. engages in the manufacture and sale of medical and pharmaceutical products. It operates through the Pharmaceuticals and Bio-Chemicals segments. The Pharmaceuticals segment deals with the research, development, production, and sale of in vitro diagnostic reagents and ethical drugs concerning renal anemia, leukemia, cancer, allergies, and hypertension. The Bio-Chemicals segment produces and sells medical and industrial raw materials such as amino acids, nucleic acid-related compounds, and healthcare products. The company was founded by Benzaburo Kato on July 1, 1949 and is headquartered in Tokyo, Japan.

Head office Japan
CEO Masashi Miyamoto
Employees 5,669
Founded 1949
Website www.kyowakirin.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today